nodes	percent_of_prediction	percent_of_DWPC	metapath
Atropine—Haemoglobin decreased—Sorafenib—liver cancer	0.0178	0.0216	CcSEcCtD
Atropine—Gastrooesophageal reflux disease—Sorafenib—liver cancer	0.0135	0.0165	CcSEcCtD
Atropine—Blood pressure increased—Sorafenib—liver cancer	0.0122	0.0149	CcSEcCtD
Atropine—Supraventricular extrasystoles—Epirubicin—liver cancer	0.0121	0.0148	CcSEcCtD
Atropine—Rash papular—Epirubicin—liver cancer	0.0121	0.0148	CcSEcCtD
Atropine—Skin exfoliation—Sorafenib—liver cancer	0.0117	0.0142	CcSEcCtD
Atropine—Supraventricular extrasystoles—Doxorubicin—liver cancer	0.0112	0.0137	CcSEcCtD
Atropine—Rash papular—Doxorubicin—liver cancer	0.0112	0.0137	CcSEcCtD
Atropine—Retrosternal pain—Epirubicin—liver cancer	0.0112	0.0137	CcSEcCtD
Atropine—Sinus tachycardia—Epirubicin—liver cancer	0.0112	0.0137	CcSEcCtD
Atropine—Retrosternal pain—Doxorubicin—liver cancer	0.0104	0.0126	CcSEcCtD
Atropine—Sinus tachycardia—Doxorubicin—liver cancer	0.0104	0.0126	CcSEcCtD
Atropine—Eczema—Sorafenib—liver cancer	0.00988	0.012	CcSEcCtD
Atropine—Hyponatraemia—Sorafenib—liver cancer	0.00891	0.0108	CcSEcCtD
Atropine—Dehydration—Sorafenib—liver cancer	0.00825	0.01	CcSEcCtD
Atropine—Granisetron—CYP1A1—liver cancer	0.00819	1	CrCbGaD
Atropine—Blindness—Epirubicin—liver cancer	0.00816	0.00993	CcSEcCtD
Atropine—Dry skin—Sorafenib—liver cancer	0.00814	0.0099	CcSEcCtD
Atropine—Hypokalaemia—Sorafenib—liver cancer	0.00808	0.00983	CcSEcCtD
Atropine—Dysphagia—Sorafenib—liver cancer	0.00767	0.00934	CcSEcCtD
Atropine—Blindness—Doxorubicin—liver cancer	0.00755	0.00919	CcSEcCtD
Atropine—Erectile dysfunction—Sorafenib—liver cancer	0.00707	0.0086	CcSEcCtD
Atropine—Keratitis—Epirubicin—liver cancer	0.00697	0.00848	CcSEcCtD
Atropine—Acute coronary syndrome—Sorafenib—liver cancer	0.00674	0.00821	CcSEcCtD
Atropine—Myocardial infarction—Sorafenib—liver cancer	0.00671	0.00816	CcSEcCtD
Atropine—Paralysis—Epirubicin—liver cancer	0.0065	0.00792	CcSEcCtD
Atropine—Keratitis—Doxorubicin—liver cancer	0.00645	0.00785	CcSEcCtD
Atropine—Laryngitis—Epirubicin—liver cancer	0.00627	0.00763	CcSEcCtD
Atropine—Ventricular arrhythmia—Epirubicin—liver cancer	0.00611	0.00743	CcSEcCtD
Atropine—Paralysis—Doxorubicin—liver cancer	0.00602	0.00732	CcSEcCtD
Atropine—Rash erythematous—Epirubicin—liver cancer	0.0059	0.00718	CcSEcCtD
Atropine—Laryngitis—Doxorubicin—liver cancer	0.0058	0.00706	CcSEcCtD
Atropine—Feeling hot—Epirubicin—liver cancer	0.00576	0.00701	CcSEcCtD
Atropine—Flushing—Sorafenib—liver cancer	0.0057	0.00694	CcSEcCtD
Atropine—Ventricular arrhythmia—Doxorubicin—liver cancer	0.00565	0.00688	CcSEcCtD
Atropine—Ageusia—Epirubicin—liver cancer	0.00558	0.00679	CcSEcCtD
Atropine—Stinging—Epirubicin—liver cancer	0.00558	0.00679	CcSEcCtD
Atropine—Petechiae—Epirubicin—liver cancer	0.00549	0.00668	CcSEcCtD
Atropine—Arrhythmia—Sorafenib—liver cancer	0.00549	0.00668	CcSEcCtD
Atropine—Rash erythematous—Doxorubicin—liver cancer	0.00546	0.00664	CcSEcCtD
Atropine—Blood disorder—Epirubicin—liver cancer	0.00541	0.00658	CcSEcCtD
Atropine—Mental disorder—Sorafenib—liver cancer	0.00538	0.00655	CcSEcCtD
Atropine—Erythema—Sorafenib—liver cancer	0.00535	0.00651	CcSEcCtD
Atropine—Feeling hot—Doxorubicin—liver cancer	0.00533	0.00648	CcSEcCtD
Atropine—Delirium—Epirubicin—liver cancer	0.00525	0.00639	CcSEcCtD
Atropine—Dysgeusia—Sorafenib—liver cancer	0.00523	0.00637	CcSEcCtD
Atropine—Ageusia—Doxorubicin—liver cancer	0.00516	0.00628	CcSEcCtD
Atropine—Stinging—Doxorubicin—liver cancer	0.00516	0.00628	CcSEcCtD
Atropine—Petechiae—Doxorubicin—liver cancer	0.00508	0.00619	CcSEcCtD
Atropine—Blood disorder—Doxorubicin—liver cancer	0.00501	0.00609	CcSEcCtD
Atropine—Ventricular extrasystoles—Epirubicin—liver cancer	0.005	0.00609	CcSEcCtD
Atropine—Angioedema—Sorafenib—liver cancer	0.00488	0.00594	CcSEcCtD
Atropine—Delirium—Doxorubicin—liver cancer	0.00486	0.00592	CcSEcCtD
Atropine—Syncope—Sorafenib—liver cancer	0.00479	0.00583	CcSEcCtD
Atropine—Dysarthria—Epirubicin—liver cancer	0.00478	0.00581	CcSEcCtD
Atropine—Loss of consciousness—Sorafenib—liver cancer	0.0047	0.00572	CcSEcCtD
Atropine—Ventricular extrasystoles—Doxorubicin—liver cancer	0.00463	0.00563	CcSEcCtD
Atropine—Ventricular tachycardia—Epirubicin—liver cancer	0.00452	0.0055	CcSEcCtD
Atropine—Injection site reaction—Epirubicin—liver cancer	0.00449	0.00547	CcSEcCtD
Atropine—Dermatitis contact—Epirubicin—liver cancer	0.00447	0.00544	CcSEcCtD
Atropine—Dry mouth—Sorafenib—liver cancer	0.00445	0.00542	CcSEcCtD
Atropine—Dysarthria—Doxorubicin—liver cancer	0.00442	0.00538	CcSEcCtD
Atropine—Anaphylactic shock—Sorafenib—liver cancer	0.00436	0.00531	CcSEcCtD
Atropine—Skin exfoliation—Epirubicin—liver cancer	0.00431	0.00525	CcSEcCtD
Atropine—Shock—Sorafenib—liver cancer	0.00429	0.00522	CcSEcCtD
Atropine—Blood urea increased—Epirubicin—liver cancer	0.00427	0.00519	CcSEcCtD
Atropine—Ventricular tachycardia—Doxorubicin—liver cancer	0.00418	0.00509	CcSEcCtD
Atropine—Dry eye—Epirubicin—liver cancer	0.00417	0.00508	CcSEcCtD
Atropine—Injection site reaction—Doxorubicin—liver cancer	0.00416	0.00506	CcSEcCtD
Atropine—Dermatitis contact—Doxorubicin—liver cancer	0.00413	0.00503	CcSEcCtD
Atropine—Coma—Epirubicin—liver cancer	0.00413	0.00503	CcSEcCtD
Atropine—Rash maculo-papular—Epirubicin—liver cancer	0.00411	0.005	CcSEcCtD
Atropine—Pulmonary oedema—Epirubicin—liver cancer	0.00402	0.0049	CcSEcCtD
Atropine—Skin exfoliation—Doxorubicin—liver cancer	0.00399	0.00486	CcSEcCtD
Atropine—Hypertonia—Epirubicin—liver cancer	0.00396	0.00482	CcSEcCtD
Atropine—Blood urea increased—Doxorubicin—liver cancer	0.00395	0.0048	CcSEcCtD
Atropine—Dyspnoea—Sorafenib—liver cancer	0.00389	0.00473	CcSEcCtD
Atropine—Dry eye—Doxorubicin—liver cancer	0.00386	0.0047	CcSEcCtD
Atropine—Dyspepsia—Sorafenib—liver cancer	0.00384	0.00467	CcSEcCtD
Atropine—Coma—Doxorubicin—liver cancer	0.00382	0.00465	CcSEcCtD
Atropine—Rash maculo-papular—Doxorubicin—liver cancer	0.0038	0.00463	CcSEcCtD
Atropine—Fatigue—Sorafenib—liver cancer	0.00376	0.00458	CcSEcCtD
Atropine—Constipation—Sorafenib—liver cancer	0.00373	0.00454	CcSEcCtD
Atropine—Pain—Sorafenib—liver cancer	0.00373	0.00454	CcSEcCtD
Atropine—Pulmonary oedema—Doxorubicin—liver cancer	0.00372	0.00453	CcSEcCtD
Atropine—Hypertonia—Doxorubicin—liver cancer	0.00367	0.00446	CcSEcCtD
Atropine—Eczema—Epirubicin—liver cancer	0.00365	0.00444	CcSEcCtD
Atropine—Eye pain—Epirubicin—liver cancer	0.00363	0.00442	CcSEcCtD
Atropine—Gastrointestinal pain—Sorafenib—liver cancer	0.00357	0.00434	CcSEcCtD
Atropine—Urticaria—Sorafenib—liver cancer	0.00347	0.00422	CcSEcCtD
Atropine—Abdominal pain—Sorafenib—liver cancer	0.00345	0.0042	CcSEcCtD
Atropine—Body temperature increased—Sorafenib—liver cancer	0.00345	0.0042	CcSEcCtD
Atropine—Eczema—Doxorubicin—liver cancer	0.00338	0.00411	CcSEcCtD
Atropine—Eye pain—Doxorubicin—liver cancer	0.00336	0.00409	CcSEcCtD
Atropine—Hypoglycaemia—Epirubicin—liver cancer	0.00336	0.00409	CcSEcCtD
Atropine—Lethargy—Epirubicin—liver cancer	0.00335	0.00407	CcSEcCtD
Atropine—Hyponatraemia—Epirubicin—liver cancer	0.00329	0.00401	CcSEcCtD
Atropine—Osteoarthritis—Epirubicin—liver cancer	0.00328	0.00399	CcSEcCtD
Atropine—Hypersensitivity—Sorafenib—liver cancer	0.00321	0.00391	CcSEcCtD
Atropine—Asthenia—Sorafenib—liver cancer	0.00313	0.00381	CcSEcCtD
Atropine—Cardiac arrest—Epirubicin—liver cancer	0.00312	0.0038	CcSEcCtD
Atropine—Hypoglycaemia—Doxorubicin—liver cancer	0.00311	0.00379	CcSEcCtD
Atropine—Lethargy—Doxorubicin—liver cancer	0.0031	0.00377	CcSEcCtD
Atropine—Pruritus—Sorafenib—liver cancer	0.00309	0.00376	CcSEcCtD
Atropine—Ataxia—Epirubicin—liver cancer	0.00308	0.00375	CcSEcCtD
Atropine—Dehydration—Epirubicin—liver cancer	0.00305	0.00371	CcSEcCtD
Atropine—Hyponatraemia—Doxorubicin—liver cancer	0.00305	0.00371	CcSEcCtD
Atropine—Osteoarthritis—Doxorubicin—liver cancer	0.00304	0.00369	CcSEcCtD
Atropine—Dry skin—Epirubicin—liver cancer	0.00301	0.00366	CcSEcCtD
Atropine—Hypokalaemia—Epirubicin—liver cancer	0.00299	0.00363	CcSEcCtD
Atropine—Diarrhoea—Sorafenib—liver cancer	0.00298	0.00363	CcSEcCtD
Atropine—Cardiac arrest—Doxorubicin—liver cancer	0.00289	0.00351	CcSEcCtD
Atropine—Dizziness—Sorafenib—liver cancer	0.00288	0.00351	CcSEcCtD
Atropine—Abdominal distension—Epirubicin—liver cancer	0.00285	0.00347	CcSEcCtD
Atropine—Ataxia—Doxorubicin—liver cancer	0.00285	0.00347	CcSEcCtD
Atropine—Dysphagia—Epirubicin—liver cancer	0.00284	0.00345	CcSEcCtD
Atropine—Dehydration—Doxorubicin—liver cancer	0.00282	0.00344	CcSEcCtD
Atropine—Dry skin—Doxorubicin—liver cancer	0.00278	0.00339	CcSEcCtD
Atropine—Vomiting—Sorafenib—liver cancer	0.00277	0.00338	CcSEcCtD
Atropine—Hypokalaemia—Doxorubicin—liver cancer	0.00276	0.00336	CcSEcCtD
Atropine—Angina pectoris—Epirubicin—liver cancer	0.00276	0.00336	CcSEcCtD
Atropine—Rash—Sorafenib—liver cancer	0.00275	0.00335	CcSEcCtD
Atropine—Dermatitis—Sorafenib—liver cancer	0.00275	0.00334	CcSEcCtD
Atropine—Headache—Sorafenib—liver cancer	0.00273	0.00333	CcSEcCtD
Atropine—Dysuria—Epirubicin—liver cancer	0.00265	0.00323	CcSEcCtD
Atropine—Abdominal distension—Doxorubicin—liver cancer	0.00264	0.00321	CcSEcCtD
Atropine—Dysphagia—Doxorubicin—liver cancer	0.00262	0.00319	CcSEcCtD
Atropine—Nausea—Sorafenib—liver cancer	0.00259	0.00315	CcSEcCtD
Atropine—Hyperglycaemia—Epirubicin—liver cancer	0.00256	0.00311	CcSEcCtD
Atropine—Angina pectoris—Doxorubicin—liver cancer	0.00256	0.00311	CcSEcCtD
Atropine—Drowsiness—Epirubicin—liver cancer	0.00253	0.00308	CcSEcCtD
Atropine—Conjunctivitis—Epirubicin—liver cancer	0.00246	0.00299	CcSEcCtD
Atropine—Dysuria—Doxorubicin—liver cancer	0.00245	0.00299	CcSEcCtD
Atropine—Sweating—Epirubicin—liver cancer	0.00242	0.00295	CcSEcCtD
Atropine—Hyperglycaemia—Doxorubicin—liver cancer	0.00237	0.00288	CcSEcCtD
Atropine—Drowsiness—Doxorubicin—liver cancer	0.00234	0.00285	CcSEcCtD
Atropine—Bradycardia—Epirubicin—liver cancer	0.00231	0.00281	CcSEcCtD
Atropine—Conjunctivitis—Doxorubicin—liver cancer	0.00227	0.00277	CcSEcCtD
Atropine—Sweating—Doxorubicin—liver cancer	0.00224	0.00273	CcSEcCtD
Atropine—Bradycardia—Doxorubicin—liver cancer	0.00214	0.0026	CcSEcCtD
Atropine—Flushing—Epirubicin—liver cancer	0.00211	0.00256	CcSEcCtD
Atropine—Arrhythmia—Epirubicin—liver cancer	0.00203	0.00247	CcSEcCtD
Atropine—Mental disorder—Epirubicin—liver cancer	0.00199	0.00242	CcSEcCtD
Atropine—Erythema—Epirubicin—liver cancer	0.00198	0.0024	CcSEcCtD
Atropine—Flushing—Doxorubicin—liver cancer	0.00195	0.00237	CcSEcCtD
Atropine—Tension—Epirubicin—liver cancer	0.00194	0.00236	CcSEcCtD
Atropine—Dysgeusia—Epirubicin—liver cancer	0.00193	0.00235	CcSEcCtD
Atropine—Nervousness—Epirubicin—liver cancer	0.00192	0.00234	CcSEcCtD
Atropine—Arrhythmia—Doxorubicin—liver cancer	0.00188	0.00228	CcSEcCtD
Atropine—Vision blurred—Epirubicin—liver cancer	0.00186	0.00227	CcSEcCtD
Atropine—Mental disorder—Doxorubicin—liver cancer	0.00184	0.00224	CcSEcCtD
Atropine—Erythema—Doxorubicin—liver cancer	0.00183	0.00222	CcSEcCtD
Atropine—Agitation—Epirubicin—liver cancer	0.00182	0.00221	CcSEcCtD
Atropine—Tension—Doxorubicin—liver cancer	0.00179	0.00218	CcSEcCtD
Atropine—Dysgeusia—Doxorubicin—liver cancer	0.00179	0.00218	CcSEcCtD
Atropine—Nervousness—Doxorubicin—liver cancer	0.00178	0.00216	CcSEcCtD
Atropine—Vertigo—Epirubicin—liver cancer	0.00177	0.00216	CcSEcCtD
Atropine—Syncope—Epirubicin—liver cancer	0.00177	0.00216	CcSEcCtD
Atropine—Palpitations—Epirubicin—liver cancer	0.00175	0.00212	CcSEcCtD
Atropine—Loss of consciousness—Epirubicin—liver cancer	0.00174	0.00211	CcSEcCtD
Atropine—Vision blurred—Doxorubicin—liver cancer	0.00172	0.0021	CcSEcCtD
Atropine—Convulsion—Epirubicin—liver cancer	0.00171	0.00208	CcSEcCtD
Atropine—Chest pain—Epirubicin—liver cancer	0.00168	0.00205	CcSEcCtD
Atropine—Agitation—Doxorubicin—liver cancer	0.00168	0.00204	CcSEcCtD
Atropine—Anxiety—Epirubicin—liver cancer	0.00168	0.00204	CcSEcCtD
Atropine—Dry mouth—Epirubicin—liver cancer	0.00164	0.002	CcSEcCtD
Atropine—Vertigo—Doxorubicin—liver cancer	0.00164	0.002	CcSEcCtD
Atropine—Syncope—Doxorubicin—liver cancer	0.00164	0.00199	CcSEcCtD
Atropine—Confusional state—Epirubicin—liver cancer	0.00163	0.00198	CcSEcCtD
Atropine—Palpitations—Doxorubicin—liver cancer	0.00162	0.00197	CcSEcCtD
Atropine—Anaphylactic shock—Epirubicin—liver cancer	0.00161	0.00196	CcSEcCtD
Atropine—Oedema—Epirubicin—liver cancer	0.00161	0.00196	CcSEcCtD
Atropine—Loss of consciousness—Doxorubicin—liver cancer	0.00161	0.00196	CcSEcCtD
Atropine—Shock—Epirubicin—liver cancer	0.00159	0.00193	CcSEcCtD
Atropine—Convulsion—Doxorubicin—liver cancer	0.00158	0.00193	CcSEcCtD
Atropine—Tachycardia—Epirubicin—liver cancer	0.00157	0.00192	CcSEcCtD
Atropine—Hyperhidrosis—Epirubicin—liver cancer	0.00156	0.0019	CcSEcCtD
Atropine—Chest pain—Doxorubicin—liver cancer	0.00156	0.00189	CcSEcCtD
Atropine—Anxiety—Doxorubicin—liver cancer	0.00155	0.00189	CcSEcCtD
Atropine—Dry mouth—Doxorubicin—liver cancer	0.00152	0.00185	CcSEcCtD
Atropine—Hypotension—Epirubicin—liver cancer	0.00151	0.00183	CcSEcCtD
Atropine—Confusional state—Doxorubicin—liver cancer	0.0015	0.00183	CcSEcCtD
Atropine—Anaphylactic shock—Doxorubicin—liver cancer	0.00149	0.00182	CcSEcCtD
Atropine—Oedema—Doxorubicin—liver cancer	0.00149	0.00182	CcSEcCtD
Atropine—Shock—Doxorubicin—liver cancer	0.00147	0.00179	CcSEcCtD
Atropine—Insomnia—Epirubicin—liver cancer	0.00146	0.00177	CcSEcCtD
Atropine—Tachycardia—Doxorubicin—liver cancer	0.00146	0.00177	CcSEcCtD
Atropine—Hyperhidrosis—Doxorubicin—liver cancer	0.00144	0.00176	CcSEcCtD
Atropine—Dyspnoea—Epirubicin—liver cancer	0.00144	0.00175	CcSEcCtD
Atropine—Somnolence—Epirubicin—liver cancer	0.00143	0.00174	CcSEcCtD
Atropine—Dyspepsia—Epirubicin—liver cancer	0.00142	0.00173	CcSEcCtD
Atropine—Hypotension—Doxorubicin—liver cancer	0.00139	0.0017	CcSEcCtD
Atropine—Fatigue—Epirubicin—liver cancer	0.00139	0.00169	CcSEcCtD
Atropine—Pain—Epirubicin—liver cancer	0.00138	0.00168	CcSEcCtD
Atropine—Constipation—Epirubicin—liver cancer	0.00138	0.00168	CcSEcCtD
Atropine—Insomnia—Doxorubicin—liver cancer	0.00135	0.00164	CcSEcCtD
Atropine—Dyspnoea—Doxorubicin—liver cancer	0.00133	0.00162	CcSEcCtD
Atropine—Feeling abnormal—Epirubicin—liver cancer	0.00133	0.00162	CcSEcCtD
Atropine—Somnolence—Doxorubicin—liver cancer	0.00133	0.00161	CcSEcCtD
Atropine—Gastrointestinal pain—Epirubicin—liver cancer	0.00132	0.0016	CcSEcCtD
Atropine—Dyspepsia—Doxorubicin—liver cancer	0.00131	0.0016	CcSEcCtD
Atropine—Fatigue—Doxorubicin—liver cancer	0.00129	0.00157	CcSEcCtD
Atropine—Urticaria—Epirubicin—liver cancer	0.00128	0.00156	CcSEcCtD
Atropine—Pain—Doxorubicin—liver cancer	0.00128	0.00155	CcSEcCtD
Atropine—Constipation—Doxorubicin—liver cancer	0.00128	0.00155	CcSEcCtD
Atropine—Body temperature increased—Epirubicin—liver cancer	0.00127	0.00155	CcSEcCtD
Atropine—Abdominal pain—Epirubicin—liver cancer	0.00127	0.00155	CcSEcCtD
Atropine—Feeling abnormal—Doxorubicin—liver cancer	0.00123	0.0015	CcSEcCtD
Atropine—Gastrointestinal pain—Doxorubicin—liver cancer	0.00122	0.00148	CcSEcCtD
Atropine—Hypersensitivity—Epirubicin—liver cancer	0.00119	0.00145	CcSEcCtD
Atropine—Urticaria—Doxorubicin—liver cancer	0.00119	0.00144	CcSEcCtD
Atropine—Abdominal pain—Doxorubicin—liver cancer	0.00118	0.00144	CcSEcCtD
Atropine—Body temperature increased—Doxorubicin—liver cancer	0.00118	0.00144	CcSEcCtD
Atropine—Asthenia—Epirubicin—liver cancer	0.00116	0.00141	CcSEcCtD
Atropine—Pruritus—Epirubicin—liver cancer	0.00114	0.00139	CcSEcCtD
Atropine—Diarrhoea—Epirubicin—liver cancer	0.0011	0.00134	CcSEcCtD
Atropine—Hypersensitivity—Doxorubicin—liver cancer	0.0011	0.00134	CcSEcCtD
Atropine—Asthenia—Doxorubicin—liver cancer	0.00107	0.0013	CcSEcCtD
Atropine—Dizziness—Epirubicin—liver cancer	0.00107	0.0013	CcSEcCtD
Atropine—Pruritus—Doxorubicin—liver cancer	0.00106	0.00128	CcSEcCtD
Atropine—Vomiting—Epirubicin—liver cancer	0.00103	0.00125	CcSEcCtD
Atropine—Diarrhoea—Doxorubicin—liver cancer	0.00102	0.00124	CcSEcCtD
Atropine—Rash—Epirubicin—liver cancer	0.00102	0.00124	CcSEcCtD
Atropine—Dermatitis—Epirubicin—liver cancer	0.00102	0.00124	CcSEcCtD
Atropine—Headache—Epirubicin—liver cancer	0.00101	0.00123	CcSEcCtD
Atropine—Dizziness—Doxorubicin—liver cancer	0.000987	0.0012	CcSEcCtD
Atropine—Nausea—Epirubicin—liver cancer	0.000958	0.00117	CcSEcCtD
Atropine—Vomiting—Doxorubicin—liver cancer	0.000949	0.00115	CcSEcCtD
Atropine—Rash—Doxorubicin—liver cancer	0.000941	0.00114	CcSEcCtD
Atropine—Dermatitis—Doxorubicin—liver cancer	0.00094	0.00114	CcSEcCtD
Atropine—Headache—Doxorubicin—liver cancer	0.000935	0.00114	CcSEcCtD
Atropine—Nausea—Doxorubicin—liver cancer	0.000886	0.00108	CcSEcCtD
Atropine—CHRM1—Signaling by GPCR—PIK3CD—liver cancer	6.54e-05	0.000384	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PRKCE—liver cancer	6.53e-05	0.000384	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—F2—liver cancer	6.52e-05	0.000383	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—PIK3CD—liver cancer	6.52e-05	0.000383	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—APC—liver cancer	6.52e-05	0.000383	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—PIK3CG—liver cancer	6.52e-05	0.000383	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—PIK3CD—liver cancer	6.46e-05	0.000379	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—PIK3CB—liver cancer	6.28e-05	0.000369	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—IGF2—liver cancer	6.27e-05	0.000368	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—PIK3CB—liver cancer	6.26e-05	0.000368	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—IGF2—liver cancer	6.25e-05	0.000367	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—APC—liver cancer	6.24e-05	0.000367	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—PIK3CG—liver cancer	6.24e-05	0.000367	CbGpPWpGaD
Atropine—CHRM3—Metabolism—MTHFR—liver cancer	6.23e-05	0.000366	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—PIK3CB—liver cancer	6.2e-05	0.000364	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—IGF2—liver cancer	6.19e-05	0.000364	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—BRAF—liver cancer	6.13e-05	0.00036	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PPARA—liver cancer	6.12e-05	0.00036	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	5.96e-05	0.00035	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—BRAF—liver cancer	5.87e-05	0.000345	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CSF2—liver cancer	5.85e-05	0.000344	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—RAF1—liver cancer	5.84e-05	0.000343	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CSF2—liver cancer	5.83e-05	0.000343	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—RAF1—liver cancer	5.82e-05	0.000342	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—HPGDS—liver cancer	5.78e-05	0.00034	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CSF2—liver cancer	5.78e-05	0.00034	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—H2AFX—liver cancer	5.77e-05	0.000339	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—IL2—liver cancer	5.76e-05	0.000339	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—RAF1—liver cancer	5.76e-05	0.000339	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	5.75e-05	0.000338	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—H2AFX—liver cancer	5.75e-05	0.000338	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—IL2—liver cancer	5.75e-05	0.000338	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—PIK3CD—liver cancer	5.73e-05	0.000337	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—PIK3CB—liver cancer	5.7e-05	0.000335	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—H2AFX—liver cancer	5.69e-05	0.000335	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—IL2—liver cancer	5.69e-05	0.000334	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—PIK3CB—liver cancer	5.68e-05	0.000334	CbGpPWpGaD
Atropine—CHRM4—GPCR downstream signaling—PIK3CA—liver cancer	5.67e-05	0.000334	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—SERPINE1—liver cancer	5.67e-05	0.000333	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—PIK3CB—liver cancer	5.63e-05	0.000331	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—KRAS—liver cancer	5.61e-05	0.00033	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—PIK3CD—liver cancer	5.49e-05	0.000322	CbGpPWpGaD
Atropine—CHRM5—GPCR downstream signaling—PIK3CA—liver cancer	5.43e-05	0.000319	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—SERPINE1—liver cancer	5.43e-05	0.000319	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—KRAS—liver cancer	5.37e-05	0.000316	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PIK3CG—liver cancer	5.24e-05	0.000308	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	5.24e-05	0.000308	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—IL2—liver cancer	5.23e-05	0.000308	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—IL2—liver cancer	5.22e-05	0.000307	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—TERT—liver cancer	5.22e-05	0.000307	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—TERT—liver cancer	5.2e-05	0.000306	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	5.17e-05	0.000304	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—IL2—liver cancer	5.17e-05	0.000304	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PSMD10—liver cancer	5.16e-05	0.000303	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PSMA4—liver cancer	5.16e-05	0.000303	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—PIK3CA—liver cancer	5.15e-05	0.000303	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—TERT—liver cancer	5.15e-05	0.000303	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—RAF1—liver cancer	5.11e-05	0.000301	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PPARG—liver cancer	5.06e-05	0.000297	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—GOT2—liver cancer	5.02e-05	0.000295	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—PIK3CB—liver cancer	4.99e-05	0.000294	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—MTOR—liver cancer	4.99e-05	0.000294	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—PIK3CA—liver cancer	4.93e-05	0.00029	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—RAF1—liver cancer	4.9e-05	0.000288	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—PIK3CB—liver cancer	4.78e-05	0.000281	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—MTOR—liver cancer	4.78e-05	0.000281	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—KDR—liver cancer	4.77e-05	0.00028	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—HRAS—liver cancer	4.77e-05	0.00028	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—KDR—liver cancer	4.75e-05	0.00028	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—MAPK14—liver cancer	4.74e-05	0.000279	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—MAPK14—liver cancer	4.72e-05	0.000278	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CYP2E1—liver cancer	4.72e-05	0.000277	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—KDR—liver cancer	4.71e-05	0.000277	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CDKN1B—liver cancer	4.69e-05	0.000275	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—MAPK14—liver cancer	4.68e-05	0.000275	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—ESR1—liver cancer	4.65e-05	0.000273	CbGpPWpGaD
Atropine—CHRM4—GPCR downstream signaling—AKT1—liver cancer	4.64e-05	0.000272	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—ESR1—liver cancer	4.63e-05	0.000272	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PIK3CD—liver cancer	4.61e-05	0.000271	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CASP3—liver cancer	4.59e-05	0.00027	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—F2—liver cancer	4.59e-05	0.00027	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—ESR1—liver cancer	4.59e-05	0.00027	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—IL2—liver cancer	4.59e-05	0.00027	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—F2—liver cancer	4.58e-05	0.000269	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—HRAS—liver cancer	4.57e-05	0.000268	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	4.57e-05	0.000268	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—IL6—liver cancer	4.56e-05	0.000268	CbGpPWpGaD
Atropine—CHRM3—Metabolism—ALB—liver cancer	4.55e-05	0.000267	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—F2—liver cancer	4.53e-05	0.000266	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CDKN1B—liver cancer	4.49e-05	0.000264	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CCND1—liver cancer	4.47e-05	0.000263	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—JUN—liver cancer	4.46e-05	0.000262	CbGpPWpGaD
Atropine—CHRM5—GPCR downstream signaling—AKT1—liver cancer	4.44e-05	0.000261	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CTNNB1—liver cancer	4.43e-05	0.00026	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CYCS—liver cancer	4.41e-05	0.000259	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CASP3—liver cancer	4.4e-05	0.000259	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PIK3CG—liver cancer	4.39e-05	0.000258	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—APC—liver cancer	4.39e-05	0.000258	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—IL2—liver cancer	4.39e-05	0.000258	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PIK3CG—liver cancer	4.38e-05	0.000257	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—APC—liver cancer	4.38e-05	0.000257	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—IL6—liver cancer	4.37e-05	0.000257	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—MMP9—liver cancer	4.34e-05	0.000255	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PIK3CG—liver cancer	4.34e-05	0.000255	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—APC—liver cancer	4.34e-05	0.000255	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—GOT1—liver cancer	4.33e-05	0.000254	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—GGT1—liver cancer	4.33e-05	0.000254	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CDKN1A—liver cancer	4.32e-05	0.000254	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CCND1—liver cancer	4.28e-05	0.000252	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—JUN—liver cancer	4.27e-05	0.000251	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CTNNB1—liver cancer	4.24e-05	0.000249	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—MAPK8—liver cancer	4.22e-05	0.000248	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—AKT1—liver cancer	4.21e-05	0.000247	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—MMP9—liver cancer	4.16e-05	0.000244	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CDKN1A—liver cancer	4.14e-05	0.000243	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—BRAF—liver cancer	4.13e-05	0.000243	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—BRAF—liver cancer	4.12e-05	0.000242	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—BRAF—liver cancer	4.08e-05	0.00024	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—MAPK8—liver cancer	4.04e-05	0.000238	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—AKT1—liver cancer	4.03e-05	0.000237	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PIK3CB—liver cancer	4.01e-05	0.000236	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—VEGFA—liver cancer	3.9e-05	0.000229	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—GSTP1—liver cancer	3.89e-05	0.000229	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PIK3CD—liver cancer	3.86e-05	0.000227	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—STAT3—liver cancer	3.86e-05	0.000227	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PIK3CD—liver cancer	3.85e-05	0.000226	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—HMOX1—liver cancer	3.84e-05	0.000225	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—PIK3CA—liver cancer	3.83e-05	0.000225	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—SERPINE1—liver cancer	3.82e-05	0.000225	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—PIK3CA—liver cancer	3.81e-05	0.000224	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PIK3CD—liver cancer	3.81e-05	0.000224	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—SERPINE1—liver cancer	3.81e-05	0.000224	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—KRAS—liver cancer	3.78e-05	0.000222	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—PIK3CA—liver cancer	3.78e-05	0.000222	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—SERPINE1—liver cancer	3.77e-05	0.000222	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—KRAS—liver cancer	3.77e-05	0.000222	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—KRAS—liver cancer	3.73e-05	0.000219	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—VEGFA—liver cancer	3.73e-05	0.000219	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—STAT3—liver cancer	3.7e-05	0.000217	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—MYC—liver cancer	3.59e-05	0.000211	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—TGFB1—liver cancer	3.58e-05	0.00021	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—GSTM1—liver cancer	3.57e-05	0.00021	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—PIK3CA—liver cancer	3.47e-05	0.000204	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—PIK3CA—liver cancer	3.46e-05	0.000204	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—RAF1—liver cancer	3.45e-05	0.000203	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—RAF1—liver cancer	3.44e-05	0.000202	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—MYC—liver cancer	3.43e-05	0.000202	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—PIK3CA—liver cancer	3.43e-05	0.000202	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—TGFB1—liver cancer	3.43e-05	0.000201	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—RAF1—liver cancer	3.4e-05	0.0002	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CYP1A1—liver cancer	3.39e-05	0.000199	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—MTOR—liver cancer	3.37e-05	0.000198	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PIK3CB—liver cancer	3.37e-05	0.000198	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—MTOR—liver cancer	3.36e-05	0.000197	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PIK3CB—liver cancer	3.36e-05	0.000197	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—MTOR—liver cancer	3.32e-05	0.000195	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PIK3CB—liver cancer	3.32e-05	0.000195	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—KRAS—liver cancer	3.31e-05	0.000195	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—HRAS—liver cancer	3.21e-05	0.000189	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—HRAS—liver cancer	3.2e-05	0.000188	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—HRAS—liver cancer	3.17e-05	0.000187	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—KRAS—liver cancer	3.17e-05	0.000187	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CDKN1B—liver cancer	3.16e-05	0.000186	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—MTHFR—liver cancer	3.16e-05	0.000186	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CDKN1B—liver cancer	3.15e-05	0.000185	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—AKT1—liver cancer	3.13e-05	0.000184	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CDKN1B—liver cancer	3.12e-05	0.000183	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—AKT1—liver cancer	3.12e-05	0.000183	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PPARA—liver cancer	3.1e-05	0.000182	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CASP3—liver cancer	3.1e-05	0.000182	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—IL2—liver cancer	3.09e-05	0.000182	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CASP3—liver cancer	3.09e-05	0.000181	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—AKT1—liver cancer	3.09e-05	0.000181	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—IL2—liver cancer	3.08e-05	0.000181	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—IL6—liver cancer	3.08e-05	0.000181	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—IL6—liver cancer	3.07e-05	0.00018	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CASP3—liver cancer	3.06e-05	0.00018	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—IL2—liver cancer	3.05e-05	0.000179	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—PIK3CA—liver cancer	3.04e-05	0.000179	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—IL6—liver cancer	3.04e-05	0.000179	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CCND1—liver cancer	3.01e-05	0.000177	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—JUN—liver cancer	3.01e-05	0.000177	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CCND1—liver cancer	3e-05	0.000177	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—JUN—liver cancer	3e-05	0.000176	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CTNNB1—liver cancer	2.99e-05	0.000175	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CCND1—liver cancer	2.98e-05	0.000175	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CTNNB1—liver cancer	2.98e-05	0.000175	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—JUN—liver cancer	2.97e-05	0.000175	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CTNNB1—liver cancer	2.95e-05	0.000173	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—TP53—liver cancer	2.94e-05	0.000173	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—MMP9—liver cancer	2.93e-05	0.000172	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—MMP9—liver cancer	2.92e-05	0.000171	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CDKN1A—liver cancer	2.92e-05	0.000171	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—PIK3CA—liver cancer	2.92e-05	0.000171	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CDKN1A—liver cancer	2.91e-05	0.000171	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—MMP9—liver cancer	2.89e-05	0.00017	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CDKN1A—liver cancer	2.88e-05	0.000169	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—MAPK8—liver cancer	2.85e-05	0.000167	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—AKT1—liver cancer	2.84e-05	0.000167	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—MAPK8—liver cancer	2.84e-05	0.000167	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—AKT1—liver cancer	2.83e-05	0.000166	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—TP53—liver cancer	2.82e-05	0.000166	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—HRAS—liver cancer	2.82e-05	0.000166	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—MAPK8—liver cancer	2.81e-05	0.000165	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—AKT1—liver cancer	2.8e-05	0.000165	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.78e-05	0.000164	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—HRAS—liver cancer	2.7e-05	0.000159	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—IL6—liver cancer	2.7e-05	0.000158	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PIK3CG—liver cancer	2.65e-05	0.000156	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—VEGFA—liver cancer	2.63e-05	0.000154	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—VEGFA—liver cancer	2.62e-05	0.000154	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—STAT3—liver cancer	2.6e-05	0.000153	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—VEGFA—liver cancer	2.59e-05	0.000152	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—STAT3—liver cancer	2.59e-05	0.000152	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—IL6—liver cancer	2.58e-05	0.000152	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—STAT3—liver cancer	2.57e-05	0.000151	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PPARG—liver cancer	2.56e-05	0.000151	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—AKT1—liver cancer	2.49e-05	0.000146	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PIK3CA—liver cancer	2.45e-05	0.000144	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—MYC—liver cancer	2.42e-05	0.000142	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—TGFB1—liver cancer	2.41e-05	0.000142	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—MYC—liver cancer	2.41e-05	0.000142	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—TGFB1—liver cancer	2.4e-05	0.000141	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—MYC—liver cancer	2.39e-05	0.00014	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—AKT1—liver cancer	2.38e-05	0.00014	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—TGFB1—liver cancer	2.38e-05	0.00014	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PIK3CD—liver cancer	2.33e-05	0.000137	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—ALB—liver cancer	2.3e-05	0.000135	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—KRAS—liver cancer	2.23e-05	0.000131	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—KRAS—liver cancer	2.23e-05	0.000131	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—KRAS—liver cancer	2.21e-05	0.00013	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PIK3CA—liver cancer	2.05e-05	0.000121	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PIK3CA—liver cancer	2.05e-05	0.00012	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PIK3CB—liver cancer	2.03e-05	0.00012	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PIK3CA—liver cancer	2.03e-05	0.000119	CbGpPWpGaD
Atropine—CHRM3—Metabolism—AKT1—liver cancer	2e-05	0.000118	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—TP53—liver cancer	1.99e-05	0.000117	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—TP53—liver cancer	1.98e-05	0.000116	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—TP53—liver cancer	1.96e-05	0.000115	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—HRAS—liver cancer	1.9e-05	0.000112	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—HRAS—liver cancer	1.89e-05	0.000111	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—HRAS—liver cancer	1.87e-05	0.00011	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—IL6—liver cancer	1.82e-05	0.000107	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—IL6—liver cancer	1.81e-05	0.000107	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—IL6—liver cancer	1.79e-05	0.000105	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—AKT1—liver cancer	1.68e-05	9.86e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—AKT1—liver cancer	1.67e-05	9.83e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—AKT1—liver cancer	1.66e-05	9.73e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PIK3CA—liver cancer	1.24e-05	7.29e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—AKT1—liver cancer	1.01e-05	5.95e-05	CbGpPWpGaD
